AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12117873 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymeric enteral diet (PEN1) containing 35 g of lipids per 1000 kcal, high in oleate (79%) and low in linoleate (6.5%)
Number of subjects: 62
Study 12117873 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymeric enteral diet (PEN2) with high linoleate (45%) and low oleate (28%)
Number of subjects: 62
Study 12117873 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone (1 mg/kg/day)
Number of subjects: 62
Study 10408325 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 20
Study 10408325 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 20
Study 7502086 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable vacuum drainage system
Number of subjects: 120
Study 7502086 — intervention group
Group type: COMPARATOR
Intervention: Continuous high vacuum drainage system
Number of subjects: 120
Study 2109766 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy on urinary incontinence
Number of subjects: 133
Study 7018336 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium (n = 26)
Number of subjects: 60
Study 7018336 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 34)
Number of subjects: 60
Study 31257405 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (3 g/d)
Number of subjects: 200
Study 31257405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 31709557 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive defusion
Number of subjects: 88
Study 31709557 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 88
Study 31709557 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 88
Study 27627789 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamping group (intermittent clamping for 48 hours before removal)
Number of subjects: 210
Study 27627789 — intervention group
Group type: COMPARATOR
Intervention: Control group (removal without clamping)
Number of subjects: 210
Study 27627789 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamping group
Number of subjects: 210
Study 27627789 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 210
Study 26375805 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 321
Study 26375805 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient stress group
Number of subjects: 321
Study 26375805 — intervention group
Group type: EXPERIMENTAL
Intervention: Time stress group
Number of subjects: 321
Study 23343912 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple‐oriented posttest HIV counselling (COC)
Number of subjects: 1943
Study 23343912 — intervention group
Group type: COMPARATOR
Intervention: Standard posttest HIV counselling
Number of subjects: 1943
Study 21843686 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mcg buccal misoprostol
Number of subjects: 40
Study 19507081 — intervention group
Group type: COMPARATOR
Intervention: Consumption of red wine (0.4 ml ethanol per kg per day for 7.5 days)
Number of subjects: 12
Study 17713693 — intervention group
Group type: EXPERIMENTAL
Intervention: standard plus 'thought mapping' intervention
Number of subjects: 119
Study 17713693 — intervention group
Group type: COMPARATOR
Intervention: standard intervention
Number of subjects: 119
Study 15765004 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in rapid serial naming of letter sounds
Number of subjects: 0
Study 15765004 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial addition training
Number of subjects: 0
Study 15765004 — intervention group
Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 0
Study 11500583 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine before repeated defibrillation or post-shock atrial pacing
Number of subjects: 22
Study 11500583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ajmaline
Number of subjects: 22
Study 11500583 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone therapy
Number of subjects: 22
Study 9766172 — intervention group
Group type: EXPERIMENTAL
Intervention: Italian version of the Family Assessment Device (FAD), a 60-item questionnaire assessing family functioning.
Number of subjects: 340
Study 9766172 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor analysis of the Italian version of the Family Assessment Device (FAD).
Number of subjects: 340
Study 9766172 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed seven-factor model of the instrument.
Number of subjects: 340
Study 9766172 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings of the study.
Number of subjects: 340
Study 7874853 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual sodium intake (30 mmol Na+ and 65 mmol K+)
Number of subjects: 14
Study 7874853 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (+50 and +100 mmol/day)
Number of subjects: 14
Study 7874853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium intake (-50 and -100 mmol/day)
Number of subjects: 14
Study 7874853 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic arterial pressure at low sodium intake
Number of subjects: 14
Study 7874853 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional week of fixed salt intake
Number of subjects: 14
Study 3277342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger root (1 g)
Number of subjects: 80
Study 3277342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 3277342 — intervention group
Group type: COMPARATOR
Intervention: Overall (Ginger root vs Placebo)
Number of subjects: 80
Study 29134891 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4-mg
Number of subjects: 394
Study 29134891 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 394
Study 29134891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 394
Study 27340281 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenapanor
Number of subjects: 72
Study 27340281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 24939853 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype electronic stethoscope
Number of subjects: 41
Study 24939853 — intervention group
Group type: COMPARATOR
Intervention: Conventional stethoscope
Number of subjects: 41
Study 23087737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum, chewed for 30 minutes 3 times a day for 4 days
Number of subjects: 16
Study 23087737 — intervention group
Group type: COMPARATOR
Intervention: Sugar chewing gum, chewed for 30 minutes 3 times a day for 4 days
Number of subjects: 16
Study 20828492 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided exploration with ergonomic chair layout (superior)
Number of subjects: 50
Study 20828492 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided exploration with ergonomic chair layout (inferior)
Number of subjects: 50
Study 20828492 — intervention group
Group type: EXPERIMENTAL
Intervention: Free exploration with ergonomic chair layout (superior)
Number of subjects: 50
Study 20828492 — intervention group
Group type: EXPERIMENTAL
Intervention: Free exploration with ergonomic chair layout (inferior)
Number of subjects: 50
Study 20828492 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided exploration (various conditions)
Number of subjects: 50
Study 20828492 — intervention group
Group type: EXPERIMENTAL
Intervention: Free exploration (uninstructed)
Number of subjects: 50
Study 18946938 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FSH (150 IU) started during the luteal phase
Number of subjects: 42
Study 17941303 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride sealant
Number of subjects: 294
Study 17941303 — intervention group
Group type: COMPARATOR
Intervention: Nonfluoride sealant
Number of subjects: 294
Study 14499752 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 8
Study 14499752 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrrolate (placebo)
Number of subjects: 8
Study 10972172 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole for 7 days
Number of subjects: 28
Study 10972172 — intervention group
Group type: COMPARATOR
Intervention: No omeprazole treatment (Control)
Number of subjects: 28
Study 9375331 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine (1.5 mg/kg)
Number of subjects: 8
Study 8229330 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help smoking cessation guide for firefighters (FF)
Number of subjects: 105
Study 8229330 — intervention group
Group type: COMPARATOR
Intervention: American Lung Association (ALA) guide
Number of subjects: 105
Study 3915058 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofensine 15 mg
Number of subjects: 60
Study 3915058 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofensine 25 mg
Number of subjects: 60
Study 3915058 — intervention group
Group type: COMPARATOR
Intervention: Imipramine 25 mg
Number of subjects: 60
Study 30114230 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 0
Study 30114230 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 0
Study 27422602 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-day workshop with a five-hour follow-up session one month later
Number of subjects: 0
Study 27422602 — intervention group
Group type: COMPARATOR
Intervention: Two-day workshop without follow-up
Number of subjects: 0
Study 27422602 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 0
Study 24528528 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Up Program (intervention arm)
Number of subjects: 224
Study 24528528 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 224
Study 22842424 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerium nitrate-silver sulfadiazine
Number of subjects: 154
Study 22842424 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine
Number of subjects: 154
Study 20298997 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis plus transcutaneous ultrasound (TUS)
Number of subjects: 396
Study 20298997 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis alone (Control)
Number of subjects: 396
Study 18702754 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg
Number of subjects: 38
Study 18702754 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine 10 mg
Number of subjects: 38
Study 15943824 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 11
Study 15943824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 12602656 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Trauma Therapy for Battered Women (CTT‐BW)
Number of subjects: 37
Study 12602656 — intervention group
Group type: COMPARATOR
Intervention: Delayed CTT‐BW
Number of subjects: 37
Study 10226086 — intervention group
Group type: EXPERIMENTAL
Intervention: xemilofiban
Number of subjects: 0
Study 10226086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8722350 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF administration on day 1 after transplantation (group 1)
Number of subjects: 35
Study 8722350 — intervention group
Group type: COMPARATOR
Intervention: G-CSF administration on day 6 after transplantation (group 2)
Number of subjects: 35
Study 2003666 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI)
Number of subjects: 111
Study 2003666 — intervention group
Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 111
Study 2003666 — intervention group
Group type: COMPARATOR
Intervention: Video
Number of subjects: 111
Study 6362846 — intervention group
Group type: EXPERIMENTAL
Intervention: Single IV infusion of killed C. parvum vaccine
Number of subjects: 49
Study 6362846 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study 31201197 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAM/DKP
Number of subjects: 393
Study 31201197 — intervention group
Group type: COMPARATOR
Intervention: TRAM/paracetamol
Number of subjects: 393
Study 29604474 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline plus brief counseling
Number of subjects: 53
Study 29604474 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus brief counseling
Number of subjects: 53
Study 26876910 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Infant Feeding Styles Questionnaire (IFSQ) in English and Spanish
Number of subjects: 303
Study 26876910 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified IFSQ in English and Spanish
Number of subjects: 303
Study 24374400 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable Group
Number of subjects: 102
Study 24374400 — intervention group
Group type: COMPARATOR
Intervention: Reusable Group
Number of subjects: 102
Study 23020253 — intervention group
Group type: EXPERIMENTAL
Intervention: SAXA-MET (saxagliptin 5 mg/day added to metformin 1500 mg/day)
Number of subjects: 286
Study 23020253 — intervention group
Group type: COMPARATOR
Intervention: MET-UP (metformin uptitration to a maximum dose of 2500 mg/day)
Number of subjects: 286
Study 23020253 — intervention group
Group type: EXPERIMENTAL
Intervention: SAXA-MET
Number of subjects: 286
Study 23020253 — intervention group
Group type: COMPARATOR
Intervention: MET-UP
Number of subjects: 286
Study 20497522 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing for weight feedback
Number of subjects: 1500
Study 20497522 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored package intervention
Number of subjects: 1500
Study 20497522 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1500
Study 17905274 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane treatment (0.5 MAC)
Number of subjects: 280
Study 17905274 — intervention group
Group type: COMPARATOR
Intervention: Control group (no isoflurane treatment)
Number of subjects: 280
Study 14996603 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine and vitamin C infusion
Number of subjects: 0
Study 14996603 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion
Number of subjects: 0
Study 14996603 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C infusion
Number of subjects: 0
Study 14996603 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine and vitamin C together infusion
Number of subjects: 0
Study 12133744 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (print information + discussion of local strategies)
Number of subjects: 554
Study 9513803 — intervention group
Group type: EXPERIMENTAL
Intervention: Neelambari raga
Number of subjects: 8
Study 9513803 — intervention group
Group type: COMPARATOR
Intervention: Kalyani raga
Number of subjects: 8
Study 8580224 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 56
Study 8580224 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 56
Study 2563314 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 80 mg I.V. bolus followed by 12 mg/min infusion
Number of subjects: 30
Study 2563314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 4942741 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 0
Study 4942741 — intervention group
Group type: COMPARATOR
Intervention: Dapsone
Number of subjects: 0
Study 31733088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine 0.2 mg/kg
Number of subjects: 18
Study 31733088 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 18
Study 31018018 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral custom‐made ankle‐foot orthoses (AFOs) and fitted walking shoes
Number of subjects: 44
Study 31018018 — intervention group
Group type: COMPARATOR
Intervention: Fitted walking shoes
Number of subjects: 44
Study 31018018 — intervention group
Group type: COMPARATOR
Intervention: Comparison between IG and CG
Number of subjects: 44
Study 28528566 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 90
Study 28528566 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 90
Study 26083698 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week recreational skiing intervention
Number of subjects: 27
Study 26083698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no skiing intervention)
Number of subjects: 27
Study 23515377 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant VH S/D 4 S-Apr (ARTISS)
Number of subjects: 45
Study 23515377 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SoC) treatment
Number of subjects: 45
Study 21644298 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Shiqizhui (EX-B 8) only
Number of subjects: 38
Study 21644298 — intervention group
Group type: COMPARATOR
Intervention: Multi-acupoints (Shiqizhui (EX-B 8), Sanyinjiao (SP 6), Diji (SP 8), Ciliao (BL 32))
Number of subjects: 38
Study 20088412 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST 36) combined with intravenous drip of Granisetron
Number of subjects: 246
Study 20088412 — intervention group
Group type: COMPARATOR
Intervention: Intravenous drip of Granisetron only
Number of subjects: 246
Study 15716033 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy surgery
Number of subjects: 139
Study 15716033 — intervention group
Group type: COMPARATOR
Intervention: Control group with prolonged medical treatment for intractable epilepsy
Number of subjects: 139
Study 15716033 — intervention group
Group type: COMPARATOR
Intervention: General population controls
Number of subjects: 139
Study 10678500 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract containing 33% Ginkgo flavone glycosides
Number of subjects: 0
Study 10678500 — intervention group
Group type: COMPARATOR
Intervention: Superoxide dismutase (SOD)
Number of subjects: 0
Study 10678500 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaempferol
Number of subjects: 0
Study 10678500 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin
Number of subjects: 0
Study 9119715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy (ice pack placed on injection site for 15 min prior to injection)
Number of subjects: 40
Study 9119715 — intervention group
Group type: COMPARATOR
Intervention: Control group (injections according to hospital protocol)
Number of subjects: 40
Study 1826096 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestodene
Number of subjects: 10
Study 1826096 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel
Number of subjects: 10
Study 1826096 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestodene and Desogestrel
Number of subjects: 10
Study 7040930 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose methotrexate (HDMTX) with folinic acid (FA) rescue (6-hour infusion)
Number of subjects: 28
Study 7040930 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose methotrexate (HDMTX) with folinic acid (FA) rescue (24-hour infusion)
Number of subjects: 28
Study 31630504 — intervention group
Group type: EXPERIMENTAL
Intervention: Perifascial technique (20 mL of 10 mg/mL mepivacaine along the latissimus dorsi and superficial axillary fascia)
Number of subjects: 42
Study 31630504 — intervention group
Group type: COMPARATOR
Intervention: Perineural technique (20 mL of 10 mg/mL mepivacaine around radial, median, ulnar and musculocutaneous nerves)
Number of subjects: 42
Study 31630504 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 30689703 — intervention group
Group type: EXPERIMENTAL
Intervention: Neratinib 240 mg/day
Number of subjects: 2840
Study 30689703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2840
Study 29031002 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) program for 12 weeks
Number of subjects: 53
Study 29031002 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with no physical exercise for 12 weeks
Number of subjects: 53
Study 27920508 — intervention group
Group type: EXPERIMENTAL
Intervention: WB‐EMS&P (whole-body electromyostimulation with dietary supplementation)
Number of subjects: 75
Study 27920508 — intervention group
Group type: EXPERIMENTAL
Intervention: WB‐EMS (whole-body electromyostimulation without dietary supplementation)
Number of subjects: 75
Study 27920508 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 75
Study 24145800 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath videolaryngoscope
Number of subjects: 28
Study 24145800 — intervention group
Group type: COMPARATOR
Intervention: Flexible fibreoptic endoscope (FFE)
Number of subjects: 28
Study 22850565 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib treatment
Number of subjects: 50
Study 22850565 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume of liver metastases
Number of subjects: 50
Study 20668976 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reevaluation intervention (Project Positive Living through Understanding and Support)
Number of subjects: 143
Study 17069836 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation of the slow pathway
Number of subjects: 112
Study 16254468 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic children
Number of subjects: 140
Study 16254468 — intervention group
Group type: COMPARATOR
Intervention: Non-diabetic controls
Number of subjects: 140
Study 11888463 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy (Longo technique)
Number of subjects: 40
Study 9705161 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin 0.05% applied three times daily for 5 days
Number of subjects: 0
Study 9705161 — intervention group
Group type: COMPARATOR
Intervention: Capsaicin pretreatment
Number of subjects: 0
Study 9705161 — intervention group
Group type: COMPARATOR
Intervention: Non-pretreated skin
Number of subjects: 0
Study 9705161 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin-pretreated skin
Number of subjects: 0
Study 8537137 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime suspension (8 mg/kg/day, b.i.d., for 10 days)
Number of subjects: 510
Study 8537137 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate suspension (80 mg/kg/day, t.i.d., for 10 days)
Number of subjects: 510